Literature DB >> 30035324

miR-9 regulates ferroptosis by targeting glutamic-oxaloacetic transaminase GOT1 in melanoma.

Kexin Zhang1, Longfei Wu2, Peng Zhang1, Meiying Luo1, Jing Du3, Tongtong Gao1, Douglas O'Connell4, Gaoyang Wang1, Hong Wang3, Yongfei Yang1.   

Abstract

Ferroptosis is a recently recognized form of regulated cell death driven by lipid-based reactive oxygen species (ROS) accumulation. However, the molecular mechanisms of ferroptosis regulation are still largely unknown. Here we identified a novel miRNA, miR-9, as an important regulator of ferroptosis by directly targeting GOT1 in melanoma cells. Overexpression of miR-9 suppressed GOT1 by directly binding to its 3'-UTR, which subsequently reduced erastin- and RSL3-induced ferroptosis. Conversely, suppression of miR-9 increased the sensitivity of melanoma cells to erastin and RSL3. Importantly, anti-miR-9 mediated lipid ROS accumulation and ferroptotic cell death could be abrogated by inhibiting glutaminolysis process. Taken together, our findings demonstrate that miR-9 regulates ferroptosis by targeting GOT1 in melanoma cells, illustrating the important role of miRNA in ferroptosis.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  GOT1; ferroptosis; glutaminolysis; melanoma; miR-9

Mesh:

Substances:

Year:  2018        PMID: 30035324     DOI: 10.1002/mc.22878

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  43 in total

1.  Mitochondria and ferroptosis.

Authors:  Sabzali Javadov
Journal:  Curr Opin Physiol       Date:  2022-01-22

Review 2.  Non-coding RNAs in ferroptotic cancer cell death pathway: meet the new masters.

Authors:  Mehdi Rabiee Valashedi; Chia Bamshad; Nima Najafi-Ghalehlou; Amirsadegh Nikoo; Kazuo Tomita; Yoshikazu Kuwahara; Tomoaki Sato; Amaneh Mohammadi Roushandeh; Mehryar Habibi Roudkenar
Journal:  Hum Cell       Date:  2022-04-12       Impact factor: 4.174

3.  Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.

Authors:  Xiaochen Ma; Sejie Yu; Bin Zhao; Wei Bai; Yubo Cui; Jinglan Ni; Qinghua Lyu; Jun Zhao
Journal:  Front Immunol       Date:  2022-06-14       Impact factor: 8.786

4.  Bioinformatics analysis based on ferroptosis-related lncRNAs: construction of a clinical prognostic model for nasopharyngeal carcinoma and correlation analysis.

Authors:  Zuwen Dai; Yi Zhong
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

5.  Mechanism of HBV-positive liver cancer cell exosomal miR-142-3p by inducing ferroptosis of M1 macrophages to promote liver cancer progression.

Authors:  Zongqiang Hu; Hui Zhang; Wei Liu; Yanfeng Yin; Jie Jiang; Chuntao Yan; Yiting Wang; Li Li
Journal:  Transl Cancer Res       Date:  2022-05       Impact factor: 0.496

Review 6.  Regulatory pathways and drugs associated with ferroptosis in tumors.

Authors:  Dan Wang; Le Tang; Yijie Zhang; Guili Ge; Xianjie Jiang; Yongzhen Mo; Pan Wu; Xiangying Deng; Lvyuan Li; Sicheng Zuo; Qijia Yan; Shanshan Zhang; Fuyan Wang; Lei Shi; Xiayu Li; Bo Xiang; Ming Zhou; Qianjin Liao; Can Guo; Zhaoyang Zeng; Wei Xiong; Zhaojian Gong
Journal:  Cell Death Dis       Date:  2022-06-10       Impact factor: 9.685

Review 7.  Ferroptosis and Its Role in Diverse Brain Diseases.

Authors:  Abigail Weiland; Yamei Wang; Weihua Wu; Xi Lan; Xiaoning Han; Qian Li; Jian Wang
Journal:  Mol Neurobiol       Date:  2018-11-08       Impact factor: 5.590

8.  MicroRNA-15a promotes prostate cancer cell ferroptosis by inhibiting GPX4 expression.

Authors:  Po Xu; Ying Wang; Zhe Deng; Zhibo Tan; Xiaojuan Pei
Journal:  Oncol Lett       Date:  2022-01-03       Impact factor: 2.967

9.  Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.

Authors:  Hongyu Li; Xiliu Zhang; Chen Yi; Yi He; Xun Chen; Wei Zhao; Dongsheng Yu
Journal:  BMC Cancer       Date:  2021-07-20       Impact factor: 4.430

Review 10.  Emerging mechanisms and targeted therapy of ferroptosis in cancer.

Authors:  Haiyan Wang; Yan Cheng; Chao Mao; Shuang Liu; Desheng Xiao; Jun Huang; Yongguang Tao
Journal:  Mol Ther       Date:  2021-03-29       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.